IMMUTEP SAS has a total of 56 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOGEN INTERNAT NEUROSCIENCE GMBH, BIOGEN INT NEUROSCIENCE GMBH and BIOGEN IDEC INTERNAT NEUROSCIENCE GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Australia | 6 | |
#3 | United States | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | Brazil | 4 | |
#6 | China | 4 | |
#7 | Republic of Korea | 4 | |
#8 | Canada | 3 | |
#9 | Israel | 3 | |
#10 | Mexico | 3 | |
#11 | United Kingdom | 2 | |
#12 | Japan | 2 | |
#13 | Philippines | 2 | |
#14 | Cuba | 1 | |
#15 | Hong Kong | 1 | |
#16 | Singapore | 1 | |
#17 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Brignone Chrystelle | 27 |
#2 | Triebel Frederic | 17 |
#3 | Triebel Frédéric | 16 |
#4 | Chrystelle Brignone | 7 |
#5 | Jia Justin Xiaoqing | 7 |
#6 | Chen Min | 6 |
#7 | Frédéric Triebel | 5 |
#8 | Blattler Walter A | 4 |
#9 | Frey Gerhard Johann | 3 |
#10 | Justin Xiaoqing Jia | 3 |
Publication | Filing date | Title |
---|---|---|
GB202018062D0 | Treatment of cancer | |
GB202014412D0 | Treatment of coronavirus | |
WO2020221928A1 | Anti-lag-3 binding molecules | |
WO2020221924A1 | Assays | |
CN108204958A | binding assay | |
AU2016316730A1 | Anti-LAG-3 Antibodies | |
US2018271940A1 | Combined preparations for the treatment of cancer or infection | |
KR20160093076A | Combined preparations for the treatment of cancer |